Silvio E Inzucchi

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi request reprint Management of hypercalcemia. Diagnostic workup, therapeutic options for hyperparathyroidism and other common causes
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, 333 Cedar St, LCI 101, PO Box 208020, New Haven, CT 06520 8020, USA
    Postgrad Med 115:27-36. 2004
  2. ncbi request reprint Oral antihyperglycemic therapy for type 2 diabetes: scientific review
    Silvio E Inzucchi
    Endocrinology, TMP 534, Yale School of Medicine, Box 208020, New Haven, CT 06520, USA
    JAMA 287:360-72. 2002
  3. ncbi request reprint Understanding hypercalcemia. Its metabolic basis, signs, and symptoms
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, 333 Cedar St, TMP 534, PO Box 208020, New Haven, CT 06520 8020, USA
    Postgrad Med 115:69-70, 73-6. 2004
  4. ncbi request reprint The prevention of type 2 diabetes mellitus
    Silvio E Inzucchi
    Section of Endocrinology, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520 8020, USA
    Endocrinol Metab Clin North Am 34:199-219, viii. 2005
  5. ncbi request reprint Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, New Haven, CT 06520 8020, USA
    Diabetes Care 28:1680-9. 2005
  6. ncbi request reprint Clinical practice. Management of hyperglycemia in the hospital setting
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, New Haven, CT 06520 8020, USA
    N Engl J Med 355:1903-11. 2006
  7. doi request reprint New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, New Haven, CT 06520 8020, USA
    Circulation 117:574-84. 2008
  8. ncbi request reprint Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut 06520 8020, USA
    Endocrinol Metab Clin North Am 36:2-17. 2007
  9. ncbi request reprint Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study
    Frans J Th Wackers
    Yale University School of Medicine, Section of Cardiovascular Medicine, 333 Cedar St Fitkin 3, New Haven, CT 06520, USA
    Diabetes Care 30:2892-8. 2007
  10. pmc Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial
    Lawrence H Young
    Yale University School of Medicine, Section of Cardiovascular Medicine, Department of Internal Medicine, New Haven, CT 06520, USA
    JAMA 301:1547-55. 2009

Detail Information

Publications71

  1. ncbi request reprint Management of hypercalcemia. Diagnostic workup, therapeutic options for hyperparathyroidism and other common causes
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, 333 Cedar St, LCI 101, PO Box 208020, New Haven, CT 06520 8020, USA
    Postgrad Med 115:27-36. 2004
    ..In virtually all cases, the cause of an elevated serum calcium concentration can be quickly ascertained through the use of selected diagnostic tests. Effective treatment options can then be implemented...
  2. ncbi request reprint Oral antihyperglycemic therapy for type 2 diabetes: scientific review
    Silvio E Inzucchi
    Endocrinology, TMP 534, Yale School of Medicine, Box 208020, New Haven, CT 06520, USA
    JAMA 287:360-72. 2002
    ..Deciphering which agent to use in certain clinical situations is a new dilemma facing the primary care physician...
  3. ncbi request reprint Understanding hypercalcemia. Its metabolic basis, signs, and symptoms
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, 333 Cedar St, TMP 534, PO Box 208020, New Haven, CT 06520 8020, USA
    Postgrad Med 115:69-70, 73-6. 2004
    ..Effective diagnostic and therapeutic strategies for patients with elevated serum calcium concentrations require a thorough understanding of normal calcium metabolism and how it may be disrupted by disease...
  4. ncbi request reprint The prevention of type 2 diabetes mellitus
    Silvio E Inzucchi
    Section of Endocrinology, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520 8020, USA
    Endocrinol Metab Clin North Am 34:199-219, viii. 2005
    ..Recent diabetes prevention guidelines are discussed, and a practical framework for their implementation is presented...
  5. ncbi request reprint Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, New Haven, CT 06520 8020, USA
    Diabetes Care 28:1680-9. 2005
    ..We sought to determine the impact of these insulin sensitizers on outcomes in diabetic patients after hospitalization with acute myocardial infarction (AMI)...
  6. ncbi request reprint Clinical practice. Management of hyperglycemia in the hospital setting
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, New Haven, CT 06520 8020, USA
    N Engl J Med 355:1903-11. 2006
  7. doi request reprint New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, New Haven, CT 06520 8020, USA
    Circulation 117:574-84. 2008
    ....
  8. ncbi request reprint Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut 06520 8020, USA
    Endocrinol Metab Clin North Am 36:2-17. 2007
  9. ncbi request reprint Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study
    Frans J Th Wackers
    Yale University School of Medicine, Section of Cardiovascular Medicine, 333 Cedar St Fitkin 3, New Haven, CT 06520, USA
    Diabetes Care 30:2892-8. 2007
    ..The purpose of this study was to assess whether the prevalence of inducible myocardial ischemia increases over time in patients with type 2 diabetes...
  10. pmc Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial
    Lawrence H Young
    Yale University School of Medicine, Section of Cardiovascular Medicine, Department of Internal Medicine, New Haven, CT 06520, USA
    JAMA 301:1547-55. 2009
    ..Coronary artery disease (CAD) is the major cause of mortality and morbidity in patients with type 2 diabetes. But the utility of screening patients with type 2 diabetes for asymptomatic CAD is controversial...
  11. ncbi request reprint Metformin and thiazolidinedione use in Medicare patients with heart failure
    Frederick A Masoudi
    Division of Cardiology, Department of Medicine, Denver Health Medical Center, Colorado, USA
    JAMA 290:81-5. 2003
    ..Little is known about patterns of use of these antihyperglycemic drugs in diabetic patients with heart failure...
  12. doi request reprint Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes
    Kasia J Lipska
    Department of Medicine, Yale University School of Medicine, New Haven, CT 06520 8088, USA
    Circ Cardiovasc Qual Outcomes 3:236-42. 2010
    ..We examined the frequency of this practice and evaluated the associated outcomes of readmission and mortality...
  13. ncbi request reprint Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study
    Frederick A Masoudi
    Department of Medicine, Division of Cardiology MC 0960, Denver Health Medical Center, 777 Bannock St, Denver, CO 80204, USA
    Circulation 111:583-90. 2005
    ..Whether this results in adverse outcomes is unknown...
  14. ncbi request reprint Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke
    Walter N Kernan
    Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520 8025, USA
    Arch Intern Med 165:227-33. 2005
    ..We conducted this study to determine if IGT and DGT are sufficiently common among patients with TIA and ischemic stroke to warrant therapeutic trials of antihyperglycemic agents...
  15. doi request reprint Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: the updated Yale insulin infusion protocol
    Shilpa Shetty
    Department of Medicine, Griffin Hospital, Derby, Connecticut, USA
    Endocr Pract 18:363-70. 2012
    ..To report our preliminary experience with the revised, more conservative Yale insulin infusion protocol (IIP) that targets blood glucose concentrations of 120 to 160 mg/dL...
  16. ncbi request reprint Experience with the continuous glucose monitoring system in a medical intensive care unit
    Philip A Goldberg
    Section of Endocrinology, Department of Medicine, Yale New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut 06520 8020, USA
    Diabetes Technol Ther 6:339-47. 2004
    ..If further developed as a "real-time" glucose sensor, CGMS technology could ultimately prove clinically useful in the ICU, by decreasing nursing workload and/or by providing alarm signals for impending glycemic excursions...
  17. doi request reprint Inpatient management of diabetes and hyperglycemia
    Magdalena Bogun
    Section of Endocrinology, Yale University School of Medicine, New Haven, CT 06520 8056, USA
    Clin Ther 35:724-33. 2013
    ..The transition to outpatient care is another important aspect of any hospital glycemic management program...
  18. doi request reprint Glucose variability and mortality in patients hospitalized with acute myocardial infarction
    Kasia J Lipska
    Department of Internal Medicine, Yale University, New Haven, CT, USA
    Circ Cardiovasc Qual Outcomes 5:550-7. 2012
    ..Whether GV is associated with in-hospital mortality during AMI, after accounting for mean BG, is unknown...
  19. doi request reprint Evaluating inpatient glycemic management: the Quality Hyperglycemia Score
    Karrie C Hendrickson
    Decision Support, Yale New Haven Health System, New Haven, Connecticut 06519, USA
    Diabetes Technol Ther 13:753-8. 2011
    ..Lack of clear, effective performance feedback to clinicians is one element that may derail efforts to improve practice...
  20. ncbi request reprint Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes
    Mikhail Kosiborod
    Section of Cardiovascular Medicine, Yale University School of Medicine, 333 Cedar St, PO Box 208088, New Haven, CT 06520 8088, USA
    Circulation 111:3078-86. 2005
    ..The relationship between admission glucose levels and outcomes in older diabetic and nondiabetic patients with acute myocardial infarction is not well defined...
  21. doi request reprint Hospital management of hyperglycemia
    Ranee R Lleva
    Section of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8020, USA
    Curr Opin Endocrinol Diabetes Obes 18:110-8. 2011
    ..However, overly stringent control may result in hypoglycemia, which in itself is a risk factor for adverse clinical outcome. A fine balance in management is obviously important...
  22. doi request reprint Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: results from the DIAD study
    Suman Tandon
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
    Diab Vasc Dis Res 9:124-30. 2012
    ..2%) occurred in 125 high-risk men. Asymptomatic women with T2DM have significantly better cardiac outcomes than their male counterparts and represent a subgroup for which screening for coronary artery disease does not appear warranted...
  23. ncbi request reprint Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings
    Philip A Goldberg
    Department of Internal Medicine, Section of Endocrinology, Yale New Haven Hospital, Yale University School of Medicine, New Haven, CT 06520 8020, USA
    J Cardiothorac Vasc Anesth 18:690-7. 2004
    ..In this article, the authors present their experience with a safe, effective, nurse-driven IIP, which was implemented simultaneously in 2 cardiothoracic intensive care units (CTICUs)...
  24. ncbi request reprint Endocrine assessments during critical illness
    Olga V Sakharova
    Yale University School of Medicine, Department of Internal Medicine, Section of Endocrinology, 333 Cedar Street, New Haven, CT 06520 8020, USA
    Crit Care Clin 23:467-90. 2007
    ..The evaluation of hormonal status in critically ill patients is challenging and has many pitfalls. This article reviews proper assessment of glycemic status AND adrenal and thyroid function during critical care...
  25. ncbi request reprint Type 2 diabetes therapy. A pathophysiologically based approach
    Adam B Mayerson
    Yale University School of Medicine, 333 Cedar St, TMP 534, PO Box 208020, New Haven, CT 06520 8020, USA
    Postgrad Med 111:83-4, 87-92, 95. 2002
    ..However, the mechanism of action of an agent, its side effect profile, and the potential for various nonglycemic benefits may help determine which is the best drug for an individual patient...
  26. doi request reprint Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with type 2 diabetes uncontrolled by oral agents
    Olga V Sakharova
    Yale University School of Medicine, New Haven, CT, USA
    J Diabetes Complications 26:333-8. 2012
    ....
  27. ncbi request reprint Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke
    Walter N Kernan
    Department of Medicine, Yale University School of Medicine, PO Box 208025, New Haven, CT 06520 8025, USA
    Stroke 34:1431-6. 2003
    ....
  28. doi request reprint Analytic review: glucose controversies in the ICU
    Shyoko Honiden
    Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Intensive Care Med 26:135-50. 2011
    ..Finally, we will discuss specific areas of controversy that relate to the implementation of glycemic control in the intensive care unit, such as the ideal glucose target and the importance of hypoglycemia...
  29. ncbi request reprint A patient with type B insulin resistance syndrome, responsive to immune therapy
    Kathleen A Page
    Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520 8020, USA
    Nat Clin Pract Endocrinol Metab 3:835-40. 2007
    ..She remained hyperglycemic (blood glucose levels 16.7-27.8 mmol/l), despite intravenous insulin at doses as high as 30,000 U/day...
  30. ncbi request reprint Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy
    Frederick A Masoudi
    Division of Cardiology, Department of Medicine, Denver Health Medical Center, Denver, Colorado 80204, USA
    Am J Cardiol 99:113B-132B. 2007
    ..This article reviews the epidemiology of HF and diabetes, the mechanisms whereby diabetes causes HF, and the pharmacotherapy of both HF and diabetes. Specific challenges in treating patients with both HF and diabetes are also addressed...
  31. doi request reprint Scientific principles and clinical implications of perioperative glucose regulation and control
    Shamsuddin Akhtar
    Department of Anesthesiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Anesth Analg 110:478-97. 2010
    ..Until further specific data are accumulated, it is prudent to maintain glucose levels <180 mg/dL in the perioperative period, and glycemic control should always be accompanied by close glucose monitoring...
  32. pmc The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes
    Adam B Mayerson
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8020, USA
    Diabetes 51:797-802. 2002
    ....
  33. ncbi request reprint "Glucometrics"--assessing the quality of inpatient glucose management
    Philip A Goldberg
    Section of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Diabetes Technol Ther 8:560-9. 2006
    ..To facilitate advances in this nascent field, standardized metrics for inpatient glycemic control should be developed and validated...
  34. ncbi request reprint Inpatient management of diabetes mellitus
    Lee N Metchick
    Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut 06520, USA
    Am J Med 113:317-23. 2002
    ..Based on these studies and our own experience, we propose guidelines and a framework for improving the glycemic control of hospitalized patients...
  35. ncbi request reprint Treatment of diabetes in the elderly. Addressing its complexities in this high-risk group
    Olga V Sakharova
    Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Postgrad Med 118:19-26, 29. 2005
    ..Here, the authors present an overview of therapy, discussing the antidiabetic agents available and their best use in the older population with diabetes...
  36. pmc Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis
    Shanti Bansal
    Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Diabetes Care 34:204-9. 2011
    ..To estimate baseline cardiovascular risk of 1,123 participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study and to assess cardiac event rates and the effect of screening on outcomes in these higher-risk participants...
  37. ncbi request reprint "Waste not, want not": determining the optimal priming volume for intravenous insulin infusions
    Philip A Goldberg
    Section of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Diabetes Technol Ther 8:598-601. 2006
    ..In this brief report, we sought to determine the optimal priming volume required for clinical IV insulin infusions...
  38. pmc Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus
    Ather Ali
    Prevention Research Center, Yale University School of Medicine, Derby, Connecticut 06418, USA
    Endocr Pract 17:16-25. 2011
    ..To investigate the effects of daily chromium picolinate supplementation on serum measures of glucose tolerance and insulin sensitivity in patients at high risk for type 2 diabetes mellitus...
  39. ncbi request reprint Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects
    Susan Riddle Brian
    Department of Endocrinology, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    J Clin Endocrinol Metab 92:3374-7. 2007
    ..Our objective was to describe the first case of the successful use of pegvisomant during pregnancy in a woman with acromegaly...
  40. ncbi request reprint Improving clinical productivity in the academic setting: a novel incentive plan based on utility theory
    Madeline S Wilson
    Yale Internal Medicine Associates, Yale School of Medicine, 789 Howard Ave, Dana 3, New Haven, CT 06510, USA
    Acad Med 81:306-13. 2006
    ....
  41. ncbi request reprint Glycemic management of diabetes in the perioperative setting
    Silvio E Inzucchi
    Division of Endocrinology, Yale University School of Medicine, New Haven, CT 06520, USA
    Int Anesthesiol Clin 40:77-93. 2002
  42. pmc Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c
    Kasia J Lipska
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, P O Box 208088, 333 Cedar Street, SHM IE 61, New Haven, Connecticut 06520 8088, USA
    J Clin Endocrinol Metab 95:5289-95. 2010
    ..Hemoglobin A1c (A1c) was recently added to the diagnostic criteria for diabetes and prediabetes...
  43. ncbi request reprint Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit
    Philip A Goldberg
    Department of Internal Medicine, Section of Endocrinology, Yale New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Diabetes Care 27:461-7. 2004
    ..This work describes our early experience with a safe, effective, nurse-implemented IIP that provides detailed insulin dosing instructions and requires minimal physician input...
  44. ncbi request reprint Diabetes mellitus in pregnancy
    France Galerneau
    Yale University School of Medicine, Department of Obstetrics and Gynecology, 333 Cedar Street, P O Box 208063, New Haven, CT 06520 8063, USA
    Obstet Gynecol Clin North Am 31:907-33, xi-xii. 2004
    ....
  45. doi request reprint Cardiovascular effects of the DPP-4 inhibitors
    Tessey Jose
    Yale University, 333 Cedar St, LLCI 101, New Haven, CT 06520 8020, USA
    Diab Vasc Dis Res 9:109-16. 2012
    ..However, the relationship between DPP-4 inhibition and actual cardiovascular outcomes remains unknown. We therefore also review ongoing large, randomized clinical trials examining this very question...
  46. ncbi request reprint Diabetes mellitus as the presenting feature of extrahepatic cholangiocarcinoma in situ: case report and review of literature
    Daniel B Costa
    Department of Internal Medicine, Yale University School of Medicine, New, Haven, Connecticut 06520, USA
    Endocr Pract 10:417-23. 2004
    ..To report a case of newly recognized diabetes, manifested by hyperglycemic crisis, as the presenting feature of an extrahepatic cholangiocarcinoma in situ...
  47. doi request reprint Refractory pituitary granulomatosis with polyangiitis (Wegener's) treated with rituximab
    Jing Hughes
    Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT 06519, USA
    Endocr Pract 19:e1-7. 2013
    ..Central nervous system (CNS) involvement of GPA is rare, particularly in the pituitary, and can be difficult to treat...
  48. ncbi request reprint Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study
    Frans J Th Wackers
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Diabetes Care 27:1954-61. 2004
    ..To assess the prevalence and clinical predictors of silent myocardial ischemia in asymptomatic patients with type 2 diabetes and to test the effectiveness of current American Diabetes Association screening guidelines...
  49. ncbi request reprint Critical issues in endocrinology
    Philip A Goldberg
    Section of Endocrinology, Yale University School of Medicine, TMP 534, 333 Cedar Street, New Haven, CT 06520, USA
    Clin Chest Med 24:583-606, vi. 2003
    ..Other endocrine issues that are related to intensive care, such as intensive insulin therapy, relative adrenal insufficiency, and thyroid function test abnormalities are also covered in detail...
  50. ncbi request reprint Glargine and lispro: two cases of mistaken identity
    Marcy A Adlersberg
    Section of Endocrinology, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
    Diabetes Care 25:404-5. 2002
  51. ncbi request reprint Metformin in heart failure
    Silvio E Inzucchi
    Diabetes Care 30:e129. 2007
  52. ncbi request reprint Hyperglycemia and biliary tract adenocarcinoma
    Daniel B Costa
    J Gastroenterol Hepatol 21:484-5. 2006
  53. ncbi request reprint Metformin and heart failure: innocent until proven guilty
    Silvio E Inzucchi
    Diabetes Care 28:2585-7. 2005
  54. ncbi request reprint Clarification--improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings
    Philip A Goldberg
    J Cardiothorac Vasc Anesth 19:416-7. 2005
  55. ncbi request reprint Metformin: new understandings, new uses
    Ripudaman S Hundal
    Diabetes and Metabolic Disease Center, Christiana Care, Wilmington, Delaware, USA
    Drugs 63:1879-94. 2003
    ..We also discuss its potential role for a variety of insulin resistant and prediabetic states, including impaired glucose tolerance, obesity, polycystic ovary syndrome and the metabolic abnormalities associated with HIV disease...
  56. ncbi request reprint Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis
    Zachary T Bloomgarden
    Mount Sinai School of Medicine, 35 East 85th Street, New York, NY 10028, USA
    Diabetes Care 29:2137-9. 2006
  57. ncbi request reprint Counterpoint: Inpatient glucose management: a premature call to arms?
    Silvio E Inzucchi
    Dallas Diabetes and Endocrine Center, Medical City Dallas, 7777 Forest Lane, Suite C 618, Dallas, TX 75230, USA
    Diabetes Care 28:976-9. 2005
  58. ncbi request reprint Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study)
    Georgios I Papaioannou
    Cardiology Division, Henry Low Heart Center, Hartford Hospital, and University of Connecticut School of Medicine, Farmington, USA
    Am J Cardiol 94:294-9. 2004
    ..In addition, microalbuminuria is an independent predictor of endothelial dysfunction in asymptomatic patients with DM, especially in the absence of hormone replacement therapy...
  59. ncbi request reprint Value of peripheral vascular endothelial function in the detection of relative myocardial ischemia in asymptomatic type 2 diabetic patients who underwent myocardial perfusion imaging
    Georgios I Papaioannou
    Henry Low Heart Center, Cardiology Division, Hartford Hospital, CT 06102, USA
    J Nucl Cardiol 13:362-8. 2006
    ..Myocardial perfusion imaging (MPI) is an effective method of detection of coronary artery disease (CAD); however, the relationship between endothelial function and MPI in asymptomatic patients with T2DM has not been examined...
  60. ncbi request reprint The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes
    Jeroen J Bax
    Leiden University Medical Center, Leiden, The Netherlands
    J Am Coll Cardiol 48:754-60. 2006
    ....
  61. doi request reprint New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications
    Darren K McGuire
    Cardiovascular Division and Donald W Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, 5909 Harry Hines Blvd, Dallas, TX 75235 9047, USA
    Circulation 117:440-9. 2008
  62. doi request reprint Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk
    Mikhail Kosiborod
    Mid America Heart Institute of Saint Luke s Hospital, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 117:1018-27. 2008
    ..Whether metrics that incorporate multiple glucose assessments during acute myocardial infarction hospitalization are better predictors of mortality than admission glucose alone is not well defined...
  63. ncbi request reprint Diabetes mellitus, insulin resistance, hyperglycemia, and stroke
    Karen Furie
    J Philip Kistler MGH Stroke Research Center, 175 Cambridge Street, Suite 300, Boston, MA 02114, USA
    Curr Neurol Neurosci Rep 8:12-9. 2008
    ..Targeting insulin resistance as a modifiable risk factor for stroke is a novel strategy currently under investigation...
  64. ncbi request reprint Metformin therapy in patients with type 2 diabetes complicated by heart failure
    Silvio E Inzucchi
    Am Heart J 154:e45. 2007
  65. doi request reprint Subcutaneous insulin order sets and protocols: effective design and implementation strategies
    Greg Maynard
    Division of Hospital Medicine, University of California San Diego, San Diego, California 92103 8485, USA
    J Hosp Med 3:29-41. 2008
  66. ncbi request reprint New treatments for diabetes
    Zachary T Bloomgarden
    N Engl J Med 356:2219-20; author reply 2222-3. 2007
  67. doi request reprint Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts
    Jeffrey L Schnipper
    Brigham and Women s Faulkner Hospitalist Service and Division of General Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120 1613, USA
    J Hosp Med 3:66-75. 2008
  68. ncbi request reprint Cardiac imaging for risk stratification in diabetes
    Jeroen J Bax
    Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
    Diabetes Care 30:1295-304. 2007
  69. ncbi request reprint Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial
    Andrew R Hoffman
    Veterans Affairs Palo Alto Health Care System and Stanford University, Palo Alto, California 94304, USA
    J Clin Endocrinol Metab 89:2048-56. 2004
    ..GH treatment was generally well tolerated. Subjects with AGHD should receive individualized GH therapy to maintain IGF-I between the mean value and +2 SD and improve body composition and cardiovascular risk factors...
  70. ncbi request reprint Nonalcoholic fatty liver disease
    Silvio E Inzucchi
    N Engl J Med 347:768-9; author reply 768-9. 2002
  71. ncbi request reprint Lipid management in patients with diabetes: translating guidelines into action
    Silvio E Inzucchi
    Diabetes Care 26:1309-11. 2003